Jörg Reinhardt
Jörg Reinhardt is a notable Swiss pharmaceutical executive, having served as the chairman of Novartis until his recent retirement. Under his leadership, the company underwent a significant transformation, shifting from a diverse healthcare conglomerate to a focused pharmaceutical enterprise. Reinhardt's tenure has been marked by strategic decisions that have greatly influenced Novartis's direction and performance in the global pharmaceutical market.
Not in the pool (under ¢1).
Recent news mentions
Jörg Reinhardt faced criticism regarding the high salary of CEO Vas Narasimhan during the general assembly.
Das Lohnpaket für den CEO erntet an der Generalversammlung Kritik
Switzerland· 2025-03-07
Jörg Reinhardt has radically transformed Novartis over twelve years into a pure pharmaceutical company.
«In den USA liegt der CEO-Lohn im unteren Bereich»Switzerland· 2025-03-06
Jörg Reinhardt is mentioned as the outgoing president who helped transform Novartis into a pure pharmaceutical company.
Sandoz Stiftung verkauft grosses AktienpaketSwitzerland· 2025-02-26
